![]() |
OPK Biotech websites
|
![]() |
|
|
IschemiaIschemia - a decrease or lack of red blood cell flow to an organ or area of the body due to obstructed or constricted blood vessels, as in heart attack, stroke and certain medical procedures. Our development strategy for ischemia is to assess Hemopure's safety and feasibility in ischemia indications, such as cardiac surgery, wound healing and acute coronary ischemia (e.g. heart attack). In contrast to previous uses where Hemopure was administered as a red blood cell replacement, here it would be used as an oxygen-carrying drug. |
![]()
is a Resource Guide for individuals interested in the impact of OPK Biotech's Hemoglobin Based Oxygen Carriers (HBOCs) on laboratory assays. The information presented for Hemopure® also applies to Oxyglobin®.
Learn More
Oxyglobin® Solution
More than 200,000 units have been sold in the United States and Europe. Learn More |
|
©2010 OPK Biotech Legal Statement Terms of Use Privacy Policy Sitemap Home Contact Webmaster |
||